outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1081,420,7203.2020626,1012.0281903,51269.441359,0,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4790,1791,0.2906343761,0.120941472,0.6984232883,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4844,4180,0.6995513159,0.4738228217,1.0328165322,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1813,0.1932936681,0.0241944813,1.5442547303,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7929,0.3506142178,0.1757254504,0.6995590531,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4844,17686,0.538022149,0.3996287806,0.7243418063,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,1081,420,8409.1194295,1178.8479759,59985.079523,0,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4790,1791,0.646197058,0.2031299084,2.0556826963,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,4844,4180,0.7398703832,0.4817182898,1.1363657877,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1813,0.223125993,0.0278731378,1.7861357833,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7929,0.7903425958,0.2856396225,2.1868164271,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4844,17686,0.553087147,0.3945940081,0.7752408448,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1081,420,8548.7328198,1199.6951708,60916.168211,0,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4790,1791,0.6565708599,0.2093266876,2.0593900331,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4844,4180,0.7661352147,0.5016287598,1.1701146629,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1081,1813,0.2218063713,0.0276929505,1.7765556041,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4790,7929,0.7856012729,0.2820893091,2.1878509398,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4844,17686,0.5487659899,0.3886694348,0.774807805,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1081,420,8354.2722106,1171.5192067,59575.5185,0,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4790,1791,0.6277024171,0.1953813352,2.0166221302,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4844,4180,0.7066312221,0.4605050856,1.0843043859,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1081,1813,0.2251002346,0.0281140067,1.8023085809,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4790,7929,0.7904742686,0.2855659085,2.1881098222,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4844,17686,0.5575105696,0.3976420358,0.7816528617,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1081,420,8544.8858519,1199.1930102,60886.841068,0,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4790,1791,0.6448391231,0.20435758,2.0347544475,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4844,4180,0.736963404,0.482964026,1.1245455761,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1081,1813,0.2234088265,0.0278894148,1.7896217637,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4790,7929,0.7835696346,0.2810801088,2.1843643606,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4844,17686,0.5521867499,0.391178228,0.7794661997,1,1
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,421,1.6044624208,0.468335657,5.4966979797,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,0.7728177411,0.4676364039,1.2771616068,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4863,4229,0.866973739,0.7080299061,1.0615984688,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1813,1.1576191782,0.604907467,2.215350669,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7944,0.9067186678,0.6417572936,1.2810742482,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4863,17783,0.6842592831,0.593201968,0.7892940209,1,1
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,421,1.773171075,0.4963531465,6.3344731137,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,0.7699191061,0.425841725,1.3920088033,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,4863,4229,1.3306343693,1.0501813983,1.6859828479,1,1
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1813,1.3209911247,0.6417876189,2.7189953502,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7944,0.9620149649,0.6461759566,1.4322303132,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4863,17783,1.0077310808,0.8378096913,1.2121152833,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,421,1.8937976419,0.5307059534,6.7579221327,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4794,1799,0.8236060637,0.4536811902,1.4951621596,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4863,4229,1.408874819,1.1123883606,1.7843842367,1,1
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1813,1.3011468097,0.6322707612,2.6776234555,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4794,7944,0.9438532989,0.6332973299,1.4066995198,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4863,17783,0.9820534225,0.8151276864,1.183163007,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1082,421,1.7521028857,0.490802753,6.2547826048,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4794,1799,0.7375100991,0.4079570428,1.3332804417,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4863,4229,1.2527395559,0.9874142034,1.5893597535,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1082,1813,1.338936657,0.6506810357,2.7551922878,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4794,7944,0.960020113,0.6447949114,1.4293515676,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4863,17783,1.019500764,0.8477346894,1.2260696899,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1082,421,1.9046976716,0.5343349078,6.7895119089,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4794,1799,0.8034375834,0.442083689,1.4601578081,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4863,4229,1.3375004911,1.054911303,1.6957895499,1,1
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1082,1813,1.3140827421,0.6387134283,2.7035809434,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4794,7944,0.9394860668,0.6303169965,1.4003018714,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4863,17783,0.9906678194,0.8226570776,1.1929912902,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1071,417,1.1029796734,0.4461341434,2.726902162,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4740,1753,0.5399293788,0.3778206322,0.7715929446,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4646,3983,0.7860382485,0.6643552372,0.9300086662,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1071,1794,0.4915183136,0.3004116071,0.8041974643,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4740,7846,0.4767342418,0.3739595643,0.607754311,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4646,17229,0.4733275716,0.4184160666,0.5354454761,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,1071,417,2.44337113,0.904004582,6.6040179419,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4740,1753,0.7892182431,0.5242199916,1.1881756614,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,4646,3983,1.3004648471,1.0620698333,1.5923706386,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1071,1794,0.9542086771,0.5093598622,1.7875656624,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4740,7846,0.6589270008,0.493342706,0.8800875886,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4646,17229,0.7993087078,0.6782858953,0.9419249535,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1071,417,2.4594133452,0.9100924686,6.6462631119,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4740,1753,0.7932760054,0.5267270726,1.1947113665,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4646,3983,1.3098089071,1.0718320029,1.6006233892,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1071,1794,0.9553462688,0.5095438224,1.791183512,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4740,7846,0.6588383195,0.4927655527,0.8808812404,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4646,17229,0.7968665698,0.6743936588,0.9415811104,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1071,417,2.4335704938,0.9002721312,6.5783057619,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4740,1753,0.7724668674,0.5129704938,1.1632346663,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4646,3983,1.253385302,1.0249295656,1.5327635849,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1071,1794,0.9594685787,0.5123843314,1.7966590643,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4740,7846,0.6593768268,0.4937022515,0.8806477961,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4646,17229,0.8058385337,0.6834764478,0.9501069781,1,1
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1071,417,2.4700192538,0.9137078443,6.6771836892,1,0
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4740,1753,0.7823635424,0.5190995144,1.1791432961,1,0
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4646,3983,1.2685076223,1.0387973349,1.5490139738,1,1
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1071,1794,0.9587214553,0.5115483773,1.7967935577,1,0
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4740,7846,0.6577212985,0.4919884059,0.8792835388,1,1
Cancer,Solid Cancer,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4646,17229,0.8016279625,0.6782498564,0.9474493569,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1070,420,21574.890362,11480.503949,40544.900834,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4770,1788,0.6220434786,0.3361660728,1.1510325419,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4734,4105,0.6743678541,0.5479061324,0.8300180921,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1070,1806,0.6110646911,0.2934613614,1.2723993881,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4770,7910,0.5506364348,0.3719512145,0.8151619661,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4734,17504,0.5160970053,0.4399502634,0.6054232515,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,MPCD,1070,420,30707.74323,14953.658886,63059.181802,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4770,1788,1.1550240076,0.5266572291,2.5331095529,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Medicare,4734,4105,1.0747742479,0.8337431385,1.3854862856,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1070,1806,1.0195083323,0.4535856163,2.2915127865,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4770,7910,0.9915532299,0.5421365228,1.8135243918,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4734,17504,0.8087282003,0.6526513297,1.0021297318,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1070,420,30930.912993,15053.521744,63554.654841,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4770,1788,1.1459092917,0.5270068089,2.4916340412,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4734,4105,1.0804888925,0.8459687665,1.3800228722,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1070,1806,1.0244065137,0.4555743396,2.3034851045,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4770,7910,0.9946340674,0.5488699885,1.8024248888,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4734,17504,0.8015945301,0.6409229693,1.0025444889,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1070,420,30583.134512,14894.772043,62795.732211,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4770,1788,1.1373082849,0.5198688411,2.4880701295,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4734,4105,1.0470853115,0.8109027485,1.3520581249,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1070,1806,1.0234575354,0.4553576785,2.3003133058,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4770,7910,0.9914332408,0.5423682614,1.8123108246,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4734,17504,0.8114313637,0.6548741855,1.0054158075,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1070,420,30958.799672,15069.725473,63600.845206,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4770,1788,1.1340521731,0.5226608859,2.4606286144,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4734,4105,1.056601189,0.8255920164,1.3522491139,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1070,1806,1.0272815973,0.4568674645,2.3098766324,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4770,7910,0.992308628,0.5487350222,1.7944479091,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4734,17504,0.8027473079,0.6419528901,1.0038170249,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1081,421,6571.2573072,2111.2601109,20452.914529,0,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4772,1788,0.880040985,0.455979359,1.6984806878,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4763,4126,0.7762250705,0.6341712034,0.9500988958,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1810,0.4533381237,0.125006672,1.6440358836,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4772,7898,0.6003352056,0.4161948513,0.8659462221,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4763,17460,0.5393409585,0.464265298,0.6265569939,1,1
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,MPCD,1081,421,6211.9240219,1581.5059865,24399.528287,0,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4772,1788,1.2375028231,0.5082108674,3.0133421685,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Medicare,4763,4126,1.2602750124,0.9817895879,1.6177530568,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1810,0.4553410432,0.1016025618,2.0406519475,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4772,7898,0.950104735,0.5778896329,1.562061259,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4763,17460,0.8489816464,0.6903585459,1.0440514428,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1081,421,6325.2606734,1610.0787886,24849.046439,0,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4772,1788,1.253160938,0.5166033007,3.0398805707,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4763,4126,1.2931049641,1.0115396396,1.6530449059,1,1
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1081,1810,0.452569978,0.1009600758,2.028718614,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4772,7898,0.9417173821,0.5709922529,1.5531412612,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4763,17460,0.8385389632,0.6793271726,1.0350647246,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1081,421,6183.3625755,1572.7041238,24310.976337,0,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4772,1788,1.2133653876,0.4979488547,2.9566401246,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4763,4126,1.2247470561,0.9497196735,1.5794190572,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1081,1810,0.4577399712,0.1020897033,2.0523703617,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4772,7898,0.9490587334,0.5774033215,1.559936436,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4763,17460,0.8526223402,0.693448914,1.0483322423,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1081,421,6328.4749686,1609.6441069,24881.025102,0,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4772,1788,1.2360420657,0.5093633342,2.9994306333,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4763,4126,1.2618514478,0.9828555792,1.6200437887,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1081,1810,0.4543890634,0.1013117575,2.0379611012,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4772,7898,0.9386754169,0.5692209839,1.5479252579,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4763,17460,0.8408927251,0.6813975292,1.0377210729,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1079,421,26481.507446,10935.943584,64125.261002,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4784,1794,0.7691685181,0.2769751613,2.1360045662,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4819,4186,0.5719362305,0.431470982,0.7581298985,1,1
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1079,1812,1.5215203556,0.4403131523,5.2576766796,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4784,7916,0.5794773663,0.3102395711,1.0823700434,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4819,17636,0.5229730565,0.4175868297,0.6549555647,1,1
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,MPCD,1079,421,59333.998443,20262.038935,173749.70912,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4784,1794,1.7002231309,0.4165008053,6.9405836875,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Medicare,4819,4186,0.8965837608,0.637124132,1.2617045873,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1079,1812,3.9303655502,0.9807125423,15.751581317,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4784,7916,1.1374569014,0.364490172,3.5496381029,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4819,17636,0.7900182155,0.5899026359,1.0580199898,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1079,421,70040.4862,23991.729122,204473.37006,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4784,1794,1.7711294253,0.4450873027,7.047829543,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4819,4186,0.9785619318,0.6924696777,1.3828525423,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1079,1812,3.9064604884,0.9731904031,15.680830286,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4784,7916,1.1217621323,0.3729936191,3.3736509604,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4819,17636,0.755431884,0.5550856863,1.0280887176,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1079,421,58953.381594,20116.178002,172771.44799,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4784,1794,1.6607514379,0.4091239536,6.7414662826,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4819,4186,0.8679215963,0.6126452956,1.2295661173,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1079,1812,3.9642731565,0.9885587701,15.897346859,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4784,7916,1.1353922699,0.3644297998,3.5373495999,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4819,17636,0.7941536918,0.5933750409,1.0628692525,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1079,421,70372.765337,24081.897601,205645.17727,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4784,1794,1.7520926563,0.4422517249,6.9413605494,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4819,4186,0.9523189494,0.6697763484,1.3540510704,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1079,1812,3.9357064748,0.9799058706,15.807421835,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4784,7916,1.1144817622,0.3731518831,3.3285899235,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4819,17636,0.7583089867,0.5575252904,1.0314016767,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,421,1.3509142027,0.6700269462,2.7237250582,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,0.8602885144,0.6970943123,1.0616875149,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4863,4229,0.788136182,0.7260583213,0.8555216891,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1813,0.7365568546,0.5146803325,1.0540834101,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7944,0.7212933169,0.6349845918,0.819333344,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4863,17783,0.6719260426,0.6318359288,0.714559882,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,421,2.1372912841,1.0041639498,4.5490719259,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,0.9830592396,0.7629984026,1.2665891112,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,4863,4229,0.8692747917,0.7849310805,0.9626815427,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1813,1.1026597361,0.7255062816,1.6758759013,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7944,0.8462130631,0.7141192513,1.0027408543,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4863,17783,0.7475070269,0.6876776044,0.8125417371,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,421,2.3214553163,1.0898471035,4.9448723294,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4794,1799,1.0633340718,0.8257830186,1.3692208761,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4863,4229,0.9451440171,0.8544138014,1.0455088759,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1813,1.0776743028,0.7091585094,1.6376901463,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4794,7944,0.819840634,0.6936339876,0.9690105692,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4863,17783,0.7125467932,0.6540440834,0.7762824332,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1082,421,2.1429896257,1.0079336531,4.5562567749,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4794,1799,1.0002504355,0.7762590258,1.2888751054,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4863,4229,0.8933528652,0.8059938397,0.9901804485,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1082,1813,1.0968425169,0.7217194146,1.6669407565,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4794,7944,0.8472918371,0.7147672062,1.0043877935,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4863,17783,0.7460291192,0.6866203716,0.8105781152,1,1
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1082,421,2.3117942214,1.0864885403,4.9189589433,1,1
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4794,1799,1.0726798506,0.8331709358,1.3810396072,1,0
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4863,4229,0.9649083254,0.8716370246,1.0681603123,1,0
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1082,1813,1.073256655,0.7062859042,1.6308974038,1,0
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4794,7944,0.8218603348,0.6950079693,0.9718657047,1,1
Infection,Hospitalized infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4863,17783,0.7114346807,0.6532460561,0.7748065223,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,421,0.9515861,0.3495366677,2.5906183516,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,0.8343878081,0.5759111241,1.2088723157,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4863,4229,0.8741727883,0.7421248956,1.0297162491,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1813,1.6339112681,0.8065130266,3.3101338035,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7944,1.3277857253,1.0248183647,1.7203194176,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4863,17783,0.9501976595,0.8389743922,1.0761658526,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,421,1.0192557838,0.3085389328,3.367102957,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,0.9435620956,0.6100690782,1.4593583908,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,4863,4229,0.9767770162,0.7923773562,1.204089607,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1813,2.1281781266,0.8302545797,5.455124548,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7944,1.1857914521,0.8484827037,1.6571950868,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4863,17783,1.0570491977,0.8868977979,1.2598441544,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,421,1.0731390125,0.324781504,3.5458525992,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4794,1799,0.9898825409,0.6398659303,1.5313636785,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4863,4229,1.0364646549,0.8452613853,1.2709192678,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1813,2.0880239301,0.8134222109,5.359878147,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4794,7944,1.1583690019,0.8273230695,1.6218800057,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4863,17783,1.0275640638,0.8576892336,1.2310844811,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1082,421,1.031381586,0.3123269765,3.4058792739,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4794,1799,0.9741516473,0.6295104823,1.5074751868,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4863,4229,1.024391833,0.8305649371,1.2634516348,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1082,1813,2.1077049195,0.8247996397,5.3860596124,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4794,7944,1.1888356839,0.8507370104,1.6613010436,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4863,17783,1.0489187042,0.8799855782,1.2502823631,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1082,421,1.0739131112,0.3253139802,3.5451577266,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4794,1799,1.0087507796,0.6520900105,1.5604872317,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4863,4229,1.0768863148,0.8776570943,1.3213408089,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1082,1813,2.0728681325,0.8098235119,5.3058255681,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4794,7944,1.1645501886,0.8316713672,1.6306647015,1,0
Infection,Opportunistic infection,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4863,17783,1.0220124788,0.8527006105,1.2249428391,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1033,407,1.5790667565,0.6028298487,4.1362447913,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4595,1737,2.3304802949,1.3357908011,4.065860014,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4514,3966,1.4693637555,1.0965922959,1.9688537427,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1033,1785,1.0696657561,0.6380253406,1.7933219216,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4595,7832,1.5015141341,1.1511221814,1.9585624631,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4514,17426,1.034504346,0.8545768166,1.2523148546,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,1033,407,1.8391923541,0.6796301674,4.977160635,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4595,1737,2.4636321254,1.3543278359,4.4815465566,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,4514,3966,1.7886809148,1.2472517769,2.5651432005,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1033,1785,1.0379935192,0.5868570496,1.8359335491,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4595,7832,1.470774419,1.0873703177,1.9893658641,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4514,17426,1.2524731801,0.9496566129,1.6518487269,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1033,407,2.0114317593,0.7402225037,5.4657318601,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4595,1737,2.671606515,1.4611171043,4.8849482016,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4514,3966,1.9615540742,1.3613265206,2.826430197,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1033,1785,1.0184697364,0.5752556257,1.8031646412,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4595,7832,1.4410519437,1.0643945021,1.9509972106,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4514,17426,1.2181852161,0.9223121258,1.6089729053,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1033,407,1.8388801703,0.6795126496,4.9763316141,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4595,1737,2.459915328,1.3524863085,4.4741180614,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4514,3966,1.7846093277,1.2502127385,2.5474308128,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1033,1785,1.0383960098,0.587138151,1.8364779588,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4595,7832,1.4708706516,1.087435801,1.9895063889,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4514,17426,1.2530411288,0.9486706086,1.6550655794,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1033,407,2.0156752677,0.7415960525,5.4786521193,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4595,1737,2.6667029051,1.4584104235,4.8760652487,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4514,3966,1.9525071144,1.3598145323,2.8035323503,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1033,1785,1.019196082,0.5757239352,1.8042686607,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4595,7832,1.4410951005,1.0644285156,1.9510517224,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4514,17426,1.2194505545,0.922097142,1.6126930528,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1061,414,5.7338562949,0.7647600615,42.990095414,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4681,1776,0.9823299067,0.6169713655,1.5640467281,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4694,4072,1.3764939185,1.0390734795,1.8234855813,1,1
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1061,1797,1.0810250224,0.5921274325,1.9735871622,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4681,7890,1.2700340869,0.9577690163,1.6841081248,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4694,17603,1.2617651085,1.04175093,1.5282455174,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1061,414,8.3800299284,1.0612970853,66.168938531,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4681,1776,0.6788672914,0.399652901,1.1531526434,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4694,4072,1.6021754068,1.138147608,2.2553893854,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1061,1797,1.0963358484,0.4842839374,2.4819164948,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4681,7890,1.0853222012,0.7921502258,1.4869960798,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4694,17603,1.4014897553,1.0749847239,1.8271641359,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1061,414,8.6565127757,1.0962538622,68.355712142,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4681,1776,0.6991435715,0.4119357078,1.1865971419,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4694,4072,1.6496736791,1.1760824166,2.3139732465,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1061,1797,1.0875119355,0.4798093903,2.4649000909,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4681,7890,1.073444291,0.7819894877,1.4735270281,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4694,17603,1.3838836129,1.0589320367,1.8085521902,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1061,414,8.3895642624,1.0625153505,66.243549782,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4681,1776,0.6828691657,0.401263239,1.1621057006,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4694,4072,1.616870176,1.153970831,2.2654551534,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1061,1797,1.0947136536,0.4833661232,2.4792759068,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4681,7890,1.0852787943,0.7921527654,1.4868723721,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4694,17603,1.3992632826,1.071859692,1.8266735363,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1061,414,8.6486705145,1.0951578246,68.300202938,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4681,1776,0.7014076068,0.412824949,1.191722138,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4694,4072,1.6603147371,1.1886296214,2.3191791427,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1061,1797,1.0865707237,0.4792646918,2.463431915,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4681,7890,1.0739135216,0.7821977526,1.4744228657,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4694,17603,1.3825747219,1.0569136742,1.8085799325,1,1
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1081,420,831230.32139,265322.44056,2604166.6349,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4791,1798,365587.76274,163780.84144,816056.45134,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4852,4219,1.743713345,0.7707540778,3.9448850377,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1812,4.5401147659,0.4714787318,43.719134493,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4791,7941,1.6636871269,0.5085974082,5.4421332306,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4852,17766,1.1760896555,0.7015662693,1.9715698121,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,MPCD,1081,420,930489.11189,273136.49559,3169880.2662,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4791,1798,196905.13961,85205.904175,455034.59392,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Medicare,4852,4219,2.5356162409,1.0429156442,6.1647840425,1,1
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1812,6.2890289881,0.6285150078,62.929102925,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4791,7941,1.1669646864,0.3478539828,3.9148799399,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4852,17766,1.5173163198,0.8247202891,2.7915510809,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1081,420,928382.3864,266127.57967,3238649.1337,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4791,1798,196958.23775,83348.868603,465423.80322,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4852,4219,2.5840068505,1.0886815064,6.1331908042,1,1
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1081,1812,6.2706916023,0.6278964283,62.624298209,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4791,7941,1.1721740047,0.3502984211,3.9223468181,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4852,17766,1.5304986821,0.8130895532,2.8808957226,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1081,420,934918.79762,274506.94576,3184156.8006,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4791,1798,202697.56681,87575.860747,469151.01077,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4852,4219,2.6415442566,1.0564144087,6.6051314731,1,1
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1081,1812,6.23555946,0.6225136984,62.459993862,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4791,7941,1.1694100093,0.3485378023,3.9235909591,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4852,17766,1.5095518884,0.8238409351,2.7660034925,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1081,420,927572.81804,265692.38943,3238298.7508,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4791,1798,201900.46723,85699.5437,475659.4599,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4852,4219,2.6740662596,1.1017876699,6.490025761,1,1
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1081,1812,6.2284396582,0.6231064629,62.258157933,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4791,7941,1.1781566762,0.3519270351,3.9441503928,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4852,17766,1.5264117321,0.8114760108,2.8712281631,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,421,799940.63476,196936.02723,3249303.9905,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4792,1799,0.2880004981,0.040410169,2.0525597603,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4857,4222,1.4615670063,0.6144633042,3.4764942014,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1813,793818.93548,196957.7362,3199409.754,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7944,0.7086096959,0.1296140677,3.8740216235,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4857,17777,2.0748126241,1.1429313015,3.7664970936,1,1
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,421,858814.38317,199111.68007,3704263.5794,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4792,1799,0.7400487204,0.0809802406,6.7630338532,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,4857,4222,1.2802354963,0.4882896448,3.3566202835,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1813,854117.0944,199899.16487,3649420.0035,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4792,7944,1.4420243945,0.1971017623,10.550054601,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4857,17777,1.670819196,0.789952946,3.5339279382,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,421,804243.81381,184591.74743,3503992.5731,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4792,1799,0.6842787509,0.0771927201,6.0658234104,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4857,4222,1.2274234701,0.4764840779,3.161844109,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1813,897110.09917,210176.79406,3829188.3442,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4792,7944,1.472484958,0.1984973334,10.923128864,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4857,17777,1.6942598031,0.7825954138,3.6679441636,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1082,421,857917.81274,199116.3776,3696446.1803,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4792,1799,0.7346539775,0.0790697697,6.8258257037,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4857,4222,1.2646957979,0.4617759986,3.4637041899,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1082,1813,855787.90887,199855.02942,3664520.9635,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4792,7944,1.4424984725,0.1973231282,10.54514928,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4857,17777,1.6742674277,0.7982706214,3.5115552852,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1082,421,804791.12139,184702.03005,3506668.2748,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4792,1799,0.6814181,0.0758647493,6.1205056532,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4857,4222,1.2185665148,0.4570181529,3.2491145956,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1082,1813,897672.92477,210005.16033,3837127.9954,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4792,7944,1.4712883043,0.1975547284,10.957415657,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4857,17777,1.6955646073,0.7874446793,3.6509730943,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,421,1.0107778027,0.8841826286,1.1554985739,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4791,1798,1.1252418036,0.1257028639,10.072714953,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4840,4188,0.5555224435,0.3677168813,0.8392467166,1,1
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1813,0.9988790747,0.915941144,1.0893269861,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4791,7939,2.7975957781,0.512555556,15.269646471,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4840,17728,1.0025196973,0.7050971796,1.4254003172,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,421,1.022410081,0.8658080551,1.2073373163,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4791,1798,1.114799499,0.1232626254,10.082358046,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,4840,4188,0.9001210766,0.5372353662,1.5081247503,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1813,1.0099262485,0.9039102613,1.1283764229,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4791,7939,1.9428246252,0.3417632159,11.044393745,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4840,17728,1.6173486384,1.0126421463,2.5831599325,1,1
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,421,1.1315305796,0.9082643846,1.4096792457,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4791,1798,1.3871710448,0.1527181982,12.599962089,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4840,4188,1.1160544953,0.6829552074,1.8238057534,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1813,1.0042303514,0.8838179375,1.1410478968,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4791,7939,1.7856179846,0.3131655503,10.181297348,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4840,17728,1.4656294497,0.8975829093,2.3931713288,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1082,421,1.0281547381,0.8691458812,1.2162540125,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4791,1798,1.1368524023,0.1256010998,10.289984618,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4840,4188,0.9260481713,0.5546203768,1.5462201741,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1082,1813,1.0040986625,0.8955475785,1.125807437,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4791,7939,1.9442907696,0.3420059839,11.053217707,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4840,17728,1.6104064672,1.0068800944,2.5756880131,1,1
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1082,421,1.1421462361,0.9132812885,1.4283639016,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4791,1798,1.3887836533,0.1529495503,12.61017134,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4840,4188,1.1296033398,0.6942014874,1.838088406,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1082,1813,1.0030871451,0.8821597913,1.1405913424,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4791,7939,1.7862969056,0.3132395195,10.186634943,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4840,17728,1.461318326,0.8934939964,2.3900006696,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1077,419,19730.971352,9773.1191076,39834.900836,0,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4769,1783,1.0620722313,0.563375957,2.002210798,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4736,4088,0.8955219329,0.73286533,1.0942795346,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1077,1803,0.4669625005,0.2113628475,1.0316570742,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4769,7900,0.8050774214,0.5599264487,1.1575621332,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4736,17566,0.8569867055,0.7384964448,0.9944884889,1,1
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,MPCD,1077,419,22024.71237,9136.0453898,53096.053521,0,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4769,1783,1.2356073394,0.5122136033,2.9806422312,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Medicare,4736,4088,1.093439485,0.8632967831,1.3849349734,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1077,1803,0.5981282016,0.2305295103,1.5518939205,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4769,7900,1.0736737719,0.6047862465,1.9060872748,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4736,17566,1.0036010804,0.8303985852,1.2129297261,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1077,419,23395.358251,9700.1587406,56426.1681,0,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4769,1783,1.291444886,0.5385866032,3.0966791293,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4736,4088,1.1461521554,0.9110326648,1.4419513308,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1077,1803,0.5908776099,0.2277115131,1.5332397785,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4769,7900,1.0560653267,0.6023092004,1.8516635203,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4736,17566,0.9735828971,0.7977161758,1.1882216838,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1077,419,21974.028805,9120.4736041,52942.200469,0,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4769,1783,1.2209657039,0.5069490232,2.9406452756,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4736,4088,1.0752398785,0.8502425756,1.3597775852,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1077,1803,0.6005115988,0.2314350897,1.5581655345,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4769,7900,1.0730823442,0.6047427262,1.9041249568,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4736,17566,1.0061356623,0.8323043627,1.2162725758,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1077,419,23417.743412,9711.4595707,56468.412654,0,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4769,1783,1.2814739665,0.5349896043,3.0695466112,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4736,4088,1.1286279841,0.8976039219,1.4191127015,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1077,1803,0.5928841468,0.2284970774,1.5383637095,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4769,7900,1.0539168248,0.602161174,1.8445903216,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4736,17566,0.9753676369,0.7992171933,1.1903422937,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,421,1.007224128,0.8786598138,1.1545997986,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,0.5723596547,0.052400637,6.2517479325,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4860,4224,7.3794075902,0.9411145429,57.862942183,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1811,1.0015725322,0.9168627277,1.0941087548,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7943,2390046.1502,601970.15575,9489375.0883,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4860,17771,1.3816914332,0.6690762745,2.8532938458,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,421,1.016487233,0.848337346,1.2179662958,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4794,1799,1.1664865663,0.1070656002,12.708945798,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,4860,4224,8.712135733,1.0319961332,73.548055643,1,1
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1811,1.0050204969,0.8878007465,1.1377172223,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4794,7943,1103579.9377,280339.06779,4344341.6166,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4860,17771,1.3170195931,0.5256684585,3.2996855348,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,421,0.9419032423,0.7282891033,1.2181724453,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4794,1799,1.0962083693,0.1011655593,11.878279502,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4860,4224,7.9210739223,0.9270731202,67.67903277,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1811,1.0238616461,0.8964533911,1.1693777732,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4794,7943,3131494.7258,782028.74463,12539512.499,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4860,17771,1.3636406725,0.540732618,3.4388824008,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1082,421,1.0426054289,0.8517440967,1.2762355318,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4794,1799,1.2574879539,0.1157764731,13.658007638,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4860,4224,9.6837213983,1.1066080665,84.740445112,1,1
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1082,1811,0.980226924,0.8508262906,1.129307866,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4794,7943,1108111.8478,281183.35201,4366943.6985,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4860,17771,1.2972392767,0.5227873691,3.2189563873,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1082,421,0.9545706126,0.7306687756,1.2470836101,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4794,1799,1.1886913691,0.1100231346,12.842636918,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4860,4224,8.7410422501,0.9928872276,76.953170005,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1082,1811,1.0054352304,0.8643725379,1.1695188803,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4794,7943,3159792.5269,786180.65776,12699738.558,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4860,17771,1.3579855257,0.5388285159,3.422470477,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,421,1.0026345096,1.0026345096,1.0026345096,1,1
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4791,1797,1.1473211885,0.3238743547,4.0643721573,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4845,4208,0.7075103652,0.4025683832,1.2434431956,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1811,6.5811077E-6,1.659724E-6,0.0000260953,0,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4791,7939,0.810847668,0.3998708995,1.644215524,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4845,17740,0.5911702268,0.3843220772,0.909347284,1,1
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,421,0.9985462691,0.8463653623,1.1780900966,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4791,1797,0.4989174156,0.1277108815,1.9490789249,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Medicare,4845,4208,0.5276008718,0.2840431767,0.9800012912,1,1
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1811,5.6707861E-6,1.4053115E-6,0.0000228831,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4791,7939,0.6053255693,0.2708793408,1.3527020692,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4845,17740,0.4445106381,0.2773656485,0.7123798801,1,1
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,421,1.0057870756,0.8349081609,1.2116394219,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4791,1797,0.5225164256,0.1329782503,2.0531433861,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4845,4208,0.5647432457,0.3016497202,1.0573022689,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1811,5.5274415E-6,1.3675679E-6,0.0000223408,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4791,7939,0.6017618316,0.2678989349,1.3516936979,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4845,17740,0.43655312,0.271727005,0.7013606416,1,1
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1082,421,1.0015599336,0.8467616442,1.1846572262,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4791,1797,0.5043023705,0.1297638257,1.9598750228,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4845,4208,0.5361111155,0.2855806095,1.0064238208,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1082,1811,5.6502477E-6,1.3993455E-6,0.0000228145,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4791,7939,0.6056063333,0.2710606754,1.3530514168,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4845,17740,0.4432372266,0.2770270246,0.7091699423,1,1
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1082,421,1.0075222835,0.8353103251,1.2152383625,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4791,1797,0.5252758212,0.1341456166,2.0568297004,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4845,4208,0.5722533693,0.3032968339,1.0797142671,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1082,1811,5.5119712E-6,1.3631467E-6,0.000022288,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4791,7939,0.6027563409,0.268515808,1.3530495996,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4845,17740,0.4356056664,0.2714819725,0.6989498967,1,1
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1077,420,2.4018399756,0.3022548495,19.085997386,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4776,1794,0.710690101,0.354491826,1.4248013146,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4740,4088,0.811789119,0.6590352571,0.9999488901,1,1
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1077,1805,0.8670285551,0.3629442543,2.0712230774,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4776,7853,0.3986917616,0.2617684828,0.6072355201,1,1
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4740,17217,0.5862973739,0.5032676273,0.683025476,1,1
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,1077,420,2.2799656897,0.2786855616,18.652719271,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4776,1794,1.1706704857,0.5378276685,2.5481570888,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,4740,4088,0.9589754629,0.7470962607,1.2309443734,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1077,1805,0.7651895494,0.2984884929,1.9616000633,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4776,7853,0.5825543654,0.3396504107,0.9991732027,1,1
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4740,17217,0.6890835141,0.5659715268,0.8389752256,1,1
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1077,420,2.3363535112,0.2853647789,19.128316222,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4776,1794,1.2003293746,0.5515381569,2.6123135626,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4740,4088,1.0055145431,0.7824515773,1.2921687753,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1077,1805,0.7575179283,0.2956968882,1.9406136306,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4776,7853,0.5750152036,0.3346916272,0.9879018702,1,1
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4740,17217,0.6738708728,0.5523442632,0.8221357285,1,1
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1077,420,2.2871045423,0.2794826294,18.716179963,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4776,1794,1.1869356749,0.5445716552,2.5870173058,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4740,4088,0.9773428625,0.7572282272,1.2614414475,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1077,1805,0.7617712877,0.2970517191,1.9535167027,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4776,7853,0.5834927743,0.3401409302,1.0009492756,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4740,17217,0.6872536121,0.5652236343,0.8356294725,1,1
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1077,420,2.3329773042,0.284841751,19.108094524,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4776,1794,1.2106339469,0.5558511501,2.6367392659,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4740,4088,1.021448375,0.7913320519,1.3184816416,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1077,1805,0.7546588492,0.2944650781,1.9340493017,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4776,7853,0.576819233,0.3355995364,0.9914209988,1,1
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4740,17217,0.6725603513,0.551794582,0.8197569184,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1070,416,1.3297511203,0.4507774066,3.922641233,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4757,1785,1.0791173247,0.6474033076,1.7987152472,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4691,4050,0.8112263925,0.6856049379,0.959865111,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1070,1798,0.5589464102,0.3251520867,0.9608460234,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4757,7863,1.0279167293,0.7663997551,1.3786705897,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4691,17391,0.8020532126,0.7055493194,0.911756752,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,1070,416,1.7634319271,0.526399691,5.9074733788,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4757,1785,1.1481204071,0.6672233329,1.9756210612,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,4691,4050,0.9935742683,0.7908111674,1.248325602,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1070,1798,0.7786469322,0.3785278078,1.6017080713,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4757,7863,1.086547852,0.7790644309,1.5153897264,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4691,17391,0.9639111315,0.7936924681,1.1706356135,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1070,416,1.8351783022,0.5482760972,6.1426704869,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4757,1785,1.1940510481,0.6919583776,2.0604677272,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4691,4050,1.0375969725,0.8340111505,1.290878997,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1070,1798,0.7706697883,0.3741941575,1.5872292787,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4757,7863,1.0726305087,0.7686354448,1.4968555198,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4691,17391,0.9449039651,0.771752983,1.15690321,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1070,416,1.7784180996,0.5296483191,5.9714546861,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4757,1785,1.1831928488,0.6874475939,2.0364393299,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4691,4050,1.035777422,0.8229782656,1.3036004871,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1070,1798,0.7704950359,0.373392155,1.5899171754,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4757,7863,1.0891623932,0.7808482392,1.5192129012,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4691,17391,0.9564626262,0.7878808648,1.1611155902,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1070,416,1.8315391703,0.5458394105,6.1456458942,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4757,1785,1.2163590368,0.7052413459,2.0979049441,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4691,4050,1.0733587017,0.861118805,1.3379093521,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1070,1798,0.7645212136,0.3701823264,1.5789319057,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4757,7863,1.0783961037,0.7726812834,1.5050683658,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4691,17391,0.9397809494,0.7677588426,1.150345895,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1060,416,3.2030796394,0.9845841438,10.420357916,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4662,1759,1.6416961138,1.0915984452,2.4690087657,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4588,4034,1.3413576604,1.0916905973,1.6481229918,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1060,1797,1.9097603455,1.1265341289,3.2375269277,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4662,7879,2.0352639081,1.5927860004,2.6006627221,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4588,17529,1.6044824845,1.3830012438,1.8614329196,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1060,416,2.6627623605,0.7210437051,9.8333892085,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4662,1759,1.162472905,0.7067501593,1.9120522818,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4588,4034,1.2103811105,0.9460383826,1.5485866742,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1060,1797,1.3220377369,0.6684335779,2.6147456315,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4662,7879,1.6874034768,1.2809635525,2.2228036761,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4588,17529,1.4613943203,1.2060715222,1.7707684164,1,1
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1060,416,2.6618584349,0.7188713016,9.8564100579,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4662,1759,1.1621931551,0.7073978834,1.909382204,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4588,4034,1.2154998865,0.950295132,1.554716976,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1060,1797,1.3250480708,0.6701611758,2.6198957105,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4662,7879,1.6907601957,1.2813929279,2.2309082384,1,1
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4588,17529,1.4594910077,1.2005254788,1.7743180291,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1060,416,2.6631502167,0.7211171104,9.8352527962,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4662,1759,1.1651407675,0.7073280875,1.9192691936,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4588,4034,1.214502031,0.9491947161,1.5539648065,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1060,1797,1.3213558383,0.6680485255,2.6135545318,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4662,7879,1.687415837,1.2810026675,2.2227683667,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4588,17529,1.4606188927,1.2050757669,1.7703513823,1,1
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1060,416,2.6601335241,0.7183563529,9.8506964363,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4662,1759,1.1643907329,0.7079605871,1.9150865226,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4588,4034,1.219494342,0.9534961914,1.5596983644,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1060,1797,1.3244960157,0.6698301734,2.6190066755,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4662,7879,1.6912079541,1.2817000577,2.231555134,1,1
PsO/PsA,Psoriasis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4588,17529,1.4589791375,1.1999087651,1.7739849775,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1038,403,1.2232715753,0.5324619442,2.8103291949,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4548,1730,0.8143339382,0.5901823771,1.1236183741,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4404,3939,1.2449320089,0.9925437575,1.5614986193,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1038,1793,1.5399050759,0.9081788931,2.6110578663,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4548,7854,2.0244872998,1.5734262918,2.6048559431,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4404,17467,1.8994356979,1.6057717505,2.2468049829,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1038,403,1.4531930017,0.5908189897,3.5743094532,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4548,1730,0.7574615703,0.5231091602,1.0968036391,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4404,3939,1.1792691997,0.9022452273,1.5413501822,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1038,1793,1.6070337771,0.8680266785,2.9752052844,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4548,7854,2.081064105,1.5760724474,2.7478608716,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4404,17467,1.7456289884,1.4110175737,2.1595907959,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1038,403,1.5175940326,0.617106337,3.7320823163,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4548,1730,0.7874714519,0.5453553001,1.1370775849,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4404,3939,1.2283836385,0.942904576,1.6002959385,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1038,1793,1.5900503834,0.858362717,2.9454450569,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4548,7854,2.0510946185,1.5508340222,2.712726877,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4404,17467,1.709708115,1.3777893243,2.1215883931,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1038,403,1.4576256903,0.5926695802,3.584919362,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4548,1730,0.7668965543,0.5290387507,1.1116961172,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4404,3939,1.2036907957,0.920018327,1.5748289889,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1038,1793,1.6025431728,0.8655069118,2.9672144562,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4548,7854,2.0798653417,1.5753695596,2.7459206718,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4404,17467,1.7403984796,1.406565923,2.153462428,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1038,403,1.5158545257,0.6164274513,3.7276324054,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4548,1730,0.7933534978,0.5490877309,1.1462827105,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4404,3939,1.2480274234,0.9571081273,1.6273735488,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1038,1793,1.5873022489,0.8568238616,2.9405441914,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4548,7854,2.0519306034,1.5515466333,2.7136916873,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4404,17467,1.706695771,1.3751355338,2.1181988125,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1018,394,0.9294839129,0.4959841984,1.741870703,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4488,1706,1.198463626,0.8709163891,1.6491997175,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4540,3998,1.6853249726,1.3518547687,2.1010542915,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1018,1753,0.8664576959,0.5859753345,1.2811954609,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4488,7732,0.8651795353,0.7236597967,1.0343750362,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4540,17481,1.463427971,1.2640933601,1.694195614,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1018,394,0.9147922699,0.4306424006,1.9432477993,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4488,1706,1.2605488776,0.8759652454,1.8139800421,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4540,3998,1.444504944,1.1150708996,1.8712662432,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1018,1753,0.9728967381,0.5902940593,1.6034856662,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4488,7732,0.8212401221,0.6705295886,1.0058248727,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4540,17481,1.2500215225,1.0373794321,1.5062509996,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1018,394,0.9090943556,0.4279974028,1.9309756134,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4488,1706,1.2518029681,0.8703462226,1.8004451908,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4540,3998,1.4342895713,1.108130507,1.8564479196,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1018,1753,0.9738765107,0.590626947,1.605811355,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4488,7732,0.8218004452,0.6701673213,1.0077423208,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4540,17481,1.2507854599,1.0360009604,1.5100992436,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1018,394,0.9090757676,0.427610258,1.9326448228,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4488,1706,1.2392814713,0.8604567401,1.7848875993,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4540,3998,1.4081372102,1.0850425773,1.82744018,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1018,1753,0.9773151596,0.592625489,1.6117175839,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4488,7732,0.8198145744,0.6692203509,1.0042969188,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4540,17481,1.2556061712,1.0422424351,1.5126488848,1,1
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,MPCD,1018,394,0.9072727262,0.4269140099,1.9281255256,1,0
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Marketscan,4488,1706,1.2356491457,0.8585323138,1.7784174069,1,0
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs DMARD,Medicare,4540,3998,1.4032409227,1.082842054,1.8184416462,1,1
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,MPCD,1018,1753,0.9770409052,0.5921579341,1.612085012,1,0
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Marketscan,4488,7732,0.8191623191,0.6677976376,1.0048356976,1,0
Uveitis,Uveitis,"d Weighted, covariates (6-month daily steroid dose, sex)",TNF vs NSAID or no exposure,Medicare,4540,17481,1.2545212374,1.0393958244,1.5141715005,1,1
